Castro Cabezas Manuel, de Vries Jeanne H M, Van Oostrom Antonie J H H M, Iestra Jolein, van Staveren Wya A
St Franciscus Gasthuis Rotterdam, Department of Internal Medicine, University Medical Center Utrecht, the Netherlands.
J Am Diet Assoc. 2006 Oct;106(10):1564-9. doi: 10.1016/j.jada.2006.07.009.
Plant stanols have been recommended in combination with individualized dietary interventions to reduce plasma cholesterol concentrations. It is unclear whether plant stanols in combination with dietary guidance in patients already using optimal doses of statins will further reduce fasting and postprandial lipids compared with standard care.
This single-blind, randomized study investigated the effect of plant stanols in margarines, combined with a lipid-lowering dietary intervention, in patients already on lipid-lowering medications at maximal doses not reaching their target lipid levels. Nutrition education was based on the stages of change theory. The control group (which served as the standard care control group) was also taking optimal doses of statins. This group received a margarine without plant stanols and a leaflet with Dutch nutrition guidelines. Fasting lipids were measured once in venous samples and postprandial lipemia was assessed by self-measured triglycerides in an outpatient setting. All subjects were given a capillary triglyceride measuring device (Accutrend GCT, Roche Diagnostics, Mannheim, Germany) and were instructed to measure their capillary triglycerides at six fixed time-points throughout the day on three different days. The mean area under the triglyceride curve represented total daylong triglyceridemia, which has been shown to reflect postprandial triglyceridemia. Twenty patients were included, 11 in the intervention group and 9 in the control group.
In the plant stanol group, low-density lipoprotein cholesterol decreased significantly by 15.6% compared with a reduction of only 7.7% in the control group. The daylong triglyceridemia was similar in both groups at the beginning and at the end of the study, and no change was observed by the intervention.
Intensive dietary intervention with addition of plant stanols results in clinically relevant reduction of low-density lipoprotein cholesterol in patients optimally treated with statins, compared with similar patients on statins receiving only standard care. The use of a plant stanol-enriched margarine did not decrease postprandial triglyceridemia in these patients.
已推荐将植物甾烷醇与个体化饮食干预相结合以降低血浆胆固醇浓度。目前尚不清楚,对于已使用他汀类药物最佳剂量的患者,植物甾烷醇与饮食指导相结合是否会比标准治疗进一步降低空腹和餐后血脂。
这项单盲随机研究调查了人造黄油中的植物甾烷醇与降脂饮食干预相结合,对已服用最大剂量降脂药物但未达到目标血脂水平的患者的影响。营养教育基于行为改变阶段理论。对照组(作为标准治疗对照组)也服用他汀类药物的最佳剂量。该组接受不含植物甾烷醇的人造黄油和一份荷兰营养指南传单。在静脉样本中测量一次空腹血脂,并在门诊环境中通过自我测量甘油三酯评估餐后血脂。为所有受试者提供了一个毛细血管甘油三酯测量装置(Accutrend GCT,罗氏诊断公司,德国曼海姆),并指导他们在三天内的六个固定时间点测量毛细血管甘油三酯。甘油三酯曲线下的平均面积代表全天的甘油三酯血症,已证明其可反映餐后甘油三酯血症。纳入20名患者,干预组11名,对照组9名。
在植物甾烷醇组中,低密度脂蛋白胆固醇显著降低了15.6%,而对照组仅降低了7.7%。在研究开始和结束时,两组的全天甘油三酯血症相似,干预未观察到变化。
与仅接受标准治疗的他汀类药物治疗的类似患者相比,强化饮食干预并添加植物甾烷醇可使他汀类药物最佳治疗的患者的低密度脂蛋白胆固醇在临床上显著降低。在这些患者中,使用富含植物甾烷醇的人造黄油并未降低餐后甘油三酯血症。